Extracellular Domains of CAR Reprogram T-Cell Metabolism Without Antigen Stimulation
Aliya LakhaniiD, Ximin CheniD, Laurence C. CheniD, Mobina KherichaiD, Yvonne Y. CheniD, Junyoung O. ParkiD
Abstract
Metabolism is an indispensable part of T-cell proliferation, activation, and exhaustion, yet the metabolism of chimeric antigen receptor (CAR)-T cells remains incompletely understood. CARs are comprised of extracellular domains that determine cancer specificity, often using single-chain variable fragments (scFvs), and intracellular domains that trigger signaling upon antigen binding. Here we show that CARs differing only in the scFv reprogram T-cell metabolism differently. Even in the absence of antigens, some CARs increase proliferation and nutrient uptake in T cells. Using stable isotope tracers and mass spectrometry, we observe basal metabolic fluxes through glycolysis doubling and amino acid uptake overtaking anaplerosis in CAR-T cells harboring rituximab scFv, unlike other similar anti-CD20 scFvs. Disparate rituximab and 14g2a-based anti-GD2 CAR-T cells are similarly hypermetabolic and channel excess nutrients to nitrogen overflow metabolism. Since CAR-dependent metabolic reprogramming alters cellular energetics, nutrient utilization, and proliferation, metabolic profiling should be an integral part of CAR-T cell development.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Immunogenetic metabolomics revealed key enzymes that modulate CAR-T metabolism and function
P. A. Renauer, J. J. Park, … S. Chen·bioRxiv·Mar 14, 2023
- A balanced CAR-T cell metabolism driven by CD28 or 4-1BB co-stimulation correlates with clinical success in lymphoma patients
Molly S. Cook, Ellen King, … Anna Schurich·Cell ReportsPeer-reviewed·Jul 1, 2025
- 13C tracer analysis reveals the landscape of metabolic checkpoints in human CD8+ T cell differentiation
A. Kirchmair, N. Nemati, … Z. Trajanoski·bioRxiv·May 18, 2023
- Dynamic estimation of metabolic state during CAR T cell production and the relationship of early metabolism to final therapeutic product
Narendra Suhas Jagannathan, Wei‐Xiang Sin, … Rajeev J. Ram·bioRxiv·May 11, 2025
- Metabolic priming of GD2 TRAC-CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence
Dan Cappabianca, Dan L. Pham, … Krishanu Saha·Molecular Therapy — Methods & Clinical DevelopmentPeer-reviewed·Apr 10, 2024
- Improved CAR-T cell activity associated with increased mitochondrial function primed by galactose
G. Gross, S. Alkaderi, … E. Jacoby·bioRxiv·Sep 23, 2023